bromodeoxyuridine has been researched along with quinidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abramowski, V; Alekov, A; Giovannini, M; Hanemann, CO; Lerche, H; Utermark, T | 1 |
| Colombatto, S; Grillo, MA; Heidegger, W; Hermann, A; Kainz, V; Weiger, TM | 1 |
2 other study(ies) available for bromodeoxyuridine and quinidine
| Article | Year |
|---|---|
Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells.
Topics: Blotting, Western; Bromodeoxyuridine; Cell Division; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; DNA Primers; Enzyme Inhibitors; Humans; Immunoenzyme Techniques; Mesothelioma; Neoplasms, Mesothelial; Neurofibromatosis 2; Neurofibromin 2; Patch-Clamp Techniques; Polymerase Chain Reaction; Quinidine; Schwann Cells; Tumor Cells, Cultured | 2003 |
Potassium channel blockers quinidine and caesium halt cell proliferation in C6 glioma cells via a polyamine-dependent mechanism.
Topics: Animals; Bromodeoxyuridine; Calcium; Cell Cycle; Cell Division; Cell Line, Tumor; Cesium; Glioma; Kinetics; L-Lactate Dehydrogenase; Ornithine Decarboxylase; Potassium Channel Blockers; Quinidine; Rats | 2007 |